PERFORMANCE OF ANTENATAL HIV SCREENING STRATEGIES IN THE UNITED-KINGDOM

Citation
Pa. Tookey et al., PERFORMANCE OF ANTENATAL HIV SCREENING STRATEGIES IN THE UNITED-KINGDOM, Journal of medical screening, 5(3), 1998, pp. 133-136
Citations number
28
Categorie Soggetti
Public, Environmental & Occupation Heath
ISSN journal
09691413
Volume
5
Issue
3
Year of publication
1998
Pages
133 - 136
Database
ISI
SICI code
0969-1413(1998)5:3<133:POAHSS>2.0.ZU;2-3
Abstract
Background-In 1996 only 13.5% of previously undiagnosed HIV infected w omen were detected in pregnancy. In this study, all 265 maternity unit s in the United Kingdom were surveyed to determine the relation betwee n screening strategy, uptake of testing, and detection rate. Methods-D ata on HIV screening strategy and uptake of testing were collected in 1997 by postal questionnaire. The proportion of women with previously undiagnosed HIV infection identified during pregnancy (detection rate) was calculated using data from national obstetric HIV surveillance an d unlinked anonymous seroprevalence studies. Results-239 (90%) units r esponded; 25 of these (10%) had a universal offer strategy, 89 (37%) a selective offer, and 125 (52%) tested only women who requested it. Al l selective units offered testing to injecting drug users, but only 26 % to women who had lived abroad in high prevalence areas. Uptake was o ver 10% in only eight units, all with a universal strategy, and in 76% of selective units it was below 0.1%. The detection rate was 14.7% in universal units, 7.8% in selective units, and 7.7% in on request unit s. In universal units, detection increased by 6.3% (95% confidence int erval 3.7% to 8.8%) for every 10% increase in uptake of testing. There was evidence of both selective presentation for testing and avoidance of testing among infected women. Conclusions-All current antenatal HI V testing strategies fail to identify most infected women. Universal o ffer strategies achieve a very low uptake and a poor detection rate. U nits with selective strategies tend to test only a minority of women a t high risk and do not target all the main high risk groups.